Axa S.A. Ultragenyx Pharmaceutical Inc. Transaction History

Axa S.A.

$32.2 Billion
Q4 2024

A detailed history of Axa S.A. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Axa S.A. holds 456,588 shares of RARE stock, worth $19.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

456,588

Previous 425,390 7.33%

Holding current value

$19.4 Million

Previous $23.6 Million 18.71%

% of portfolio

0.06%

Previous 0.07%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$42.07 - $57.72 $1.31 Million - $1.8 Million	31,198 Added 7.33%	456,588 $19.2 Million
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $2,251 - $3,324	56 Added 0.01%	425,390 $23.6 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $3.46 Million - $4.78 Million	92,567 Added 27.82%	425,334 $17.5 Million
Q1 2024 May 15, 2024	BUY	$43.02 - $53.69 $2,366 - $2,952	55 Added 0.02%	332,767 $15.5 Million
Q4 2023 Jul 16, 2024	SELL	$31.73 - $49.19 $1,745 - $2,705	-55 Reduced 0.02%	332,712 $15.9 Million
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $374,001 - $579,802	-11,787 Reduced 3.42%	332,712 $15.9 Million
Q3 2023 Nov 14, 2023	SELL	$34.92 - $46.66 $25,177 - $33,641	-721 Reduced 0.21%	344,499 $12.3 Million
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $903,832 - $1.26 Million	24,199 Added 7.54%	345,220 $15.9 Million
Q1 2023 May 15, 2023	SELL	$36.99 - $48.71 $15,239 - $20,068	-412 Reduced 0.13%	321,021 $12.9 Million
Q4 2022 Feb 14, 2023	SELL	$33.72 - $46.33 $32,573 - $44,754	-966 Reduced 0.3%	321,433 $14.9 Million
Q3 2022 Feb 14, 2023	BUY	$39.96 - $66.14 $3.87 Million - $6.4 Million	96,761 Added 42.88%	322,399 $13.4 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $3.87 Million - $6.4 Million	96,761 Added 42.88%	322,399 $13.4 Million
Q2 2022 Feb 14, 2023	SELL	$45.8 - $85.4 $110,607 - $206,241	-2,415 Reduced 1.06%	225,638 $13.5 Million
Q2 2022 Aug 15, 2022	SELL	$45.8 - $85.4 $110,607 - $206,241	-2,415 Reduced 1.06%	225,638 $13.5 Million
Q1 2022 Feb 14, 2023	SELL	$62.2 - $84.4 $5.87 Million - $7.96 Million	-94,346 Reduced 29.26%	228,053 $16.6 Million
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $106,735 - $144,830	-1,716 Reduced 0.75%	228,053 $16.6 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $814,937 - $971,380	11,056 Added 5.06%	229,769 $19.3 Million
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $2.32 Million - $3.04 Million	29,735 Added 15.73%	218,713 $19.7 Million
Q2 2021 Aug 13, 2021	BUY	$92.19 - $115.71 $4.08 Million - $5.12 Million	44,223 Added 30.55%	188,978 $18 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $1.98 Million - $3.11 Million	-18,519 Reduced 11.34%	144,755 $16.5 Million
Q4 2020 Feb 12, 2021	SELL	$84.4 - $177.39 $5.34 Million - $11.2 Million	-63,323 Reduced 27.95%	163,274 $22.6 Million
Q3 2020 Nov 13, 2020	SELL	$72.98 - $90.0 $37,292 - $45,990	-511 Reduced 0.23%	226,597 $18.6 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $78.22 $3.26 Million - $5.44 Million	-69,509 Reduced 23.43%	227,108 $17.8 Million
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $2.47 Million - $4.6 Million	-73,145 Reduced 19.78%	296,617 $13.2 Million
Q4 2019 Feb 18, 2020	BUY	$36.08 - $45.83 $1.46 Million - $1.85 Million	40,407 Added 12.27%	369,762 $15.8 Million
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $1.38 Million - $2.04 Million	32,364 Added 10.9%	329,355 $14.1 Million
Q2 2019 Aug 13, 2019	BUY	$54.93 - $74.36 $197,802 - $267,770	3,601 Added 1.23%	296,991 $18.9 Million
Q1 2019 May 14, 2019	BUY	$39.87 - $69.36 $4.68 Million - $8.14 Million	117,365 Added 66.68%	293,390 $20.4 Million
Q4 2018 Feb 13, 2019	BUY	$38.89 - $77.3 $3.16 Million - $6.28 Million	81,242 Added 85.71%	176,025 $7.65 Million
Q3 2018 Nov 08, 2018	SELL	$71.81 - $90.15 $7.38 Million - $9.26 Million	-102,720 Reduced 52.01%	94,783 $7.24 Million
Q2 2018 Aug 13, 2018	SELL	$48.54 - $85.31 $3.23 Million - $5.68 Million	-66,612 Reduced 25.22%	197,503 $15.2 Million
Q1 2018 May 14, 2018	SELL	$44.33 - $58.52 $84,448 - $111,480	-1,905 Reduced 0.72%	264,115 $13.5 Million
Q4 2017 Feb 13, 2018	BUY	$43.54 - $57.32 $26,646 - $35,079	612 Added 0.23%	266,020 $12.3 Million
Q3 2017 Nov 13, 2017	BUY	$49.79 - $66.32 $13.2 Million - $17.6 Million	265,408	265,408 $14.1 Million

Others Institutions Holding RARE

# of Institutions

344

Shares Held

86.6M

Call Options Held

675K

Put Options Held

846K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.98B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account